Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Mallinckrodt

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Mallinckrodt's Japan sales performance.

Mallinckrodt

Mallinckrodt reaches tentative $1.6bn opioid settlement

Mallinckrodt reaches tentative $1.6bn opioid settlement

Mallinckrodt’s speciality US generics business – which includes its opioid drug franchise – will file for chapter 11 bankruptcy protection as part of the wide-scale agreement. ... Last September, Mallinckrodt sold off its contract development and

J&J proposes $4bn in cash to settle opioid crisis allegations

J&J proposes $4bn in cash to settle opioid crisis allegations Mallinckrodt also agreed to pay $30m to settle allegations from two Ohio counties that it helped fuel the epidemic in  September, with $24m in cash to be paid, and $6m donated

Insys gets bankruptcy court okay for Subsys sale

Insys gets bankruptcy court okay for Subsys sale crisis, while Mallinckrodt has also been reported to be at risk as it tries to pursue its own settlement deals.

Mallinckrodt offloads CDMO for $250m

Mallinckrodt offloads CDMO for $250m Mallinckrodt is also facing mounting blame for its part in the opioid epidemic in the US. ... Following the announcement of Mallinckrodt's CDMO sale, shares jumped in pre-market trading to 13%.

Humana lawsuit targets Mallinckrodt's 'billion-dollar golden goose'

Humana lawsuit targets Mallinckrodt's 'billion-dollar golden goose' Secondly, Humana alleges Mallinckrodt artificially inflated demand “by using a charitable foundation for the illegal purpose of paying patient co-pays”. ... The nonprofit allegedly used money from Mallinckrodt to provide patient assistance funds

1 2 3 4 5 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics